IFNG and hepatocellular carcinoma: SMAD3 knocked-down NK-92 cells showed enhanced cancer killing activities and enhanced IFN-γ production in vitro and better anticancer effects than NK-92 empty vector control in non-obese diabetic severe combined immunodeficiency mice bearing human hepatoma (HepG2) or melanoma (A375) in-vivo (301).